RCT Abstract - Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: Results of two randomized double-blind placebo-controlled phase 3 trials assessing safety and efficacy over 12 months - Vienna 2024

ALERT 3: Combating infection: children, adults and cystic fibrosis

Chair(s): Refika Hamutcu Ersu, Darren Taichman, Natalie Lorent, Stefan Unger

Session type: Clinical trials session

RCT Abstract - Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: Results of two randomized double-blind placebo-controlled phase 3 trials assessing safety and efficacy over 12 months

Charles Haworth

EVENTS HOME

Previous presentation

Next presentation

Session content

Charles Haworth

Replay

Abstract

Slides

Wrap-up by discussant and discussion

Natalie Lorent

Replay

Slides

RCT Abstract - Effect of adjunct betamethasone vs placebo on time to clinical stabilisation upon hospital admission and risk of rehospitalisation in children with community-acquired pneumonia

Julia Bielicki

Replay

Abstract

Slides

Late Breaking Abstract - An interventional crossover study on effectiveness air cleaning on incident infections in day care

Ville Vartiainen

Replay

Abstract

Slides

Late Breaking Abstract - 24-month outcomes of extended vs standard-course antibiotic therapy in children hospitalised with pneumonia in high-risk settings: a multi-centre RCT

Hing Cheong Kok

Replay

Abstract

Slides

Wrap-up by discussant and discussion

Stefan Unger

Replay

Slides

Closing remarks

Replay

Session aims

The ALERT sessions (Abstracts Leading to Evolution in Respiratory Medicine Trials) showcase important and very late-breaking clinical trial data from all respiratory disease areas. Presenters, discussants, session chairs and the audience will actively discuss the showcased trials.

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}